LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression

ErbB2/HER2/Neu-overexpressing breast cancers are characterized by poor survival due to high proliferation and metastasis rates and identifying downstream targets of ErbB2 should facilitate developing novel therapies for this disease. Gene expression profiling revealed the transcriptional regulator L...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Montañez-Wiscovich, ME, Seachrist, DD, Landis, MD, Visvader, J, Andersen, B, Keri, RA
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2762490/
https://ncbi.nlm.nih.gov/pubmed/19648968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2009.221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados